-
Je něco špatně v tomto záznamu ?
Galanin modulating effect on restraint stress-induced short- and long-term behavioral changes in Wistar rats
V. Klenerova, M. Flegel, P. Skopek, P. Sida, S. Hynie,
Jazyk angličtina Země Irsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- anxiolytika antagonisté a inhibitory farmakologie MeSH
- čas MeSH
- časové faktory MeSH
- chování zvířat účinky léků fyziologie MeSH
- fyzické omezení škodlivé účinky psychologie MeSH
- galanin antagonisté a inhibitory metabolismus fyziologie MeSH
- krysa rodu rattus MeSH
- lékové transportní systémy MeSH
- modely nemocí na zvířatech MeSH
- pátrací chování účinky léků fyziologie MeSH
- pohybová aktivita účinky léků fyziologie MeSH
- potkani Wistar MeSH
- psychický stres metabolismus patofyziologie prevence a kontrola MeSH
- úzkostné poruchy metabolismus patofyziologie prevence a kontrola MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The neuropeptide galanin has been recognized as a possible neurotransmitter/neuromodulator, and in addition has been implicated in anxiety- and depression-related behaviors. The present study demonstrates increased locomotion and rearing after galanin (0.3mg/kg) that was given intraperitoneally (i.p.) to intact Wistar rats which were tested 1h later in the open field (OF). These effects, which suggest an anxiolytic-like action, were blocked by i.p. administered peptidic galanin antagonist M40. Further, the locomotion increase caused by galanin and the inhibitory effect of M40 persisted for 48h without additional treatment. Rats exposed to restraint stress (lasting 60min) for three consecutive days and tested 1h after stress termination exhibited reduced locomotion and exploration in the OF. Galanin (0.3 and 1.0mg/kg) given immediately after each stress exposure prevented the decrease of locomotion and exploration induced by stress in all trials. When the test was repeated 6 days later without stress and galanin treatment the reduction of locomotion produced by stress persisted; the anti-stress behavioral effects of both galanin doses were also present. Testing performed on the 12th day after the last stress and galanin treatment with 0.3mg/kg revealed an increased locomotion compared with unstressed and stress-exposed rats. Our results demonstrate that behavioral effects of the peptide galanin are evident even after i.p. administration. These results also suggest that galanin elicits stress-modulatory action, and support the notion that the galaninergic system may serve as a drug target in stress-related conditions.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024414
- 003
- CZ-PrNML
- 005
- 20220907091428.0
- 007
- ta
- 008
- 120815s2011 ie f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.neulet.2011.06.051 $2 doi
- 035 __
- $a (PubMed)21763401
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Klenerova, Vera $u Laboratory of Neuropharmacology, Institute of Medical Biochemistry, First Faculty of Medicine, Charles University in Prague, Albertov 4, 128 00 Prague 2, Czech Republic.
- 245 10
- $a Galanin modulating effect on restraint stress-induced short- and long-term behavioral changes in Wistar rats / $c V. Klenerova, M. Flegel, P. Skopek, P. Sida, S. Hynie,
- 520 9_
- $a The neuropeptide galanin has been recognized as a possible neurotransmitter/neuromodulator, and in addition has been implicated in anxiety- and depression-related behaviors. The present study demonstrates increased locomotion and rearing after galanin (0.3mg/kg) that was given intraperitoneally (i.p.) to intact Wistar rats which were tested 1h later in the open field (OF). These effects, which suggest an anxiolytic-like action, were blocked by i.p. administered peptidic galanin antagonist M40. Further, the locomotion increase caused by galanin and the inhibitory effect of M40 persisted for 48h without additional treatment. Rats exposed to restraint stress (lasting 60min) for three consecutive days and tested 1h after stress termination exhibited reduced locomotion and exploration in the OF. Galanin (0.3 and 1.0mg/kg) given immediately after each stress exposure prevented the decrease of locomotion and exploration induced by stress in all trials. When the test was repeated 6 days later without stress and galanin treatment the reduction of locomotion produced by stress persisted; the anti-stress behavioral effects of both galanin doses were also present. Testing performed on the 12th day after the last stress and galanin treatment with 0.3mg/kg revealed an increased locomotion compared with unstressed and stress-exposed rats. Our results demonstrate that behavioral effects of the peptide galanin are evident even after i.p. administration. These results also suggest that galanin elicits stress-modulatory action, and support the notion that the galaninergic system may serve as a drug target in stress-related conditions.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a anxiolytika $x antagonisté a inhibitory $x farmakologie $7 D014151
- 650 _2
- $a úzkostné poruchy $x metabolismus $x patofyziologie $x prevence a kontrola $7 D001008
- 650 _2
- $a chování zvířat $x účinky léků $x fyziologie $7 D001522
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a lékové transportní systémy $7 D016503
- 650 _2
- $a pátrací chování $x účinky léků $x fyziologie $7 D005106
- 650 _2
- $a galanin $x antagonisté a inhibitory $x metabolismus $x fyziologie $7 D019004
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pohybová aktivita $x účinky léků $x fyziologie $7 D009043
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a fyzické omezení $x škodlivé účinky $x psychologie $7 D012149
- 650 _2
- $a psychický stres $x metabolismus $x patofyziologie $x prevence a kontrola $7 D013315
- 650 _2
- $a čas $7 D013995
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Flegel, Martin, $d 1946-2021 $7 jk01031385
- 700 1_
- $a Skopek, Petr
- 700 1_
- $a Sida, Pavel
- 700 1_
- $a Hynie, Sixtus
- 773 0_
- $w MED00003507 $t Neuroscience letters $x 1872-7972 $g Roč. 502, č. 3 (2011), s. 147-51
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21763401 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20220907091424 $b ABA008
- 999 __
- $a ok $b bmc $g 946562 $s 781742
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 502 $c 3 $d 147-51 $e 20110703 $i 1872-7972 $m Neuroscience letters $n Neurosci. lett. $x MED00003507
- LZP __
- $a Pubmed-20120815/12/02